Analysis of differential gene expression between chronic hepatitis B patients and asymptomatic hepatitis B carriers

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 1, 2007, Pages 68-73

  Tang, Cuilan ^a   Chen, Zhi ^a,b   Peng, Guoping ^a   Yang, Zhenggang ^a   Zhou, Linfu ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE   (China)

Author keywords

Asymptomatic hepatitis B virus carriage; Chronic hepatitis B; Hepatitis B virus; Real time PCR; Suppression subtractive hybridization

Indexed keywords

COMPLEMENTARY DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; DOT HYBRIDIZATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SCREENING; HEPATITIS B; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUBTRACTIVE HYBRIDIZATION; VIRUS CARRIER;

EID: 33845605881     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04371.x     Document Type: Article

References (22)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 2004; 38: 158-68.
2. Iion S. Natural history of hepatitis B and C virus infections. Oncology 2002; 2: 18-23.
3. Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int. J. Med. Sci. 2005; 2: 36-40.
4. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J. Gastroenterol. 2003; 19: 641-4.
5. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. Chinese medicine national program for prevention and treatment of viral hepatitis. Chin. J. Hepatol. 2000; 8: 324-5.
6. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology 2003; 38: 577-88.
7. Ross JW, Ashworth MD, Hurst AG, Malayer JR, Geisert RD. Analysis and characterization of differential gene expression during rapid trophoblastic elongation in the pig using suppression subtractive hybridization. Reprod. Biol. Endocrinol. 2003; 1: 23-34.
8. Huang WC, Taylor S, Nguyen TB et al. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer. DNA Cell Biol. 2002; 21: 707-15.11.
9. Shackel NA, Gorrell MD, McCaughan GW. Gene array analysis and the liver. Hepatology 2002; 36: 1313-25.
10. He N, Qin W, Xu X. Differential profile of genes expressed in hemocytes of white spot syndrome virus-resistant shrimp (Penaeus aponicus) by combining suppression subtractive hybridization and differential hybridization. Antiviral Res. 2005; 66: 39-45.10.
11. Gu XM, Zhang H, Lai MD. Bioinformatics analysis to the differentially expressed genes of normal mucosa and carcinoma of colon. Zhejiang Da Xue Bao Yi Xue Ban 2004; 33: 95-101, 124.
12. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 2003; 62: 17-21.
13. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. Human defensins. J. Mol. Med. 2005; 83: 587-95.
14. Ganz T, Selsted ME, Szklarek D et al. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 1985; 76: 1427-35.
15. Chertov O, Michiel DF, Xu L et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 1996; 271: 2935-40.
16. Legrand D, Elass E, Pierce A, Mazurier J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 2004; 17: 225-9.
17. Groot F, Geijtenbeek TB, Sanders RW et al. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 2005; 79: 3009-15.
18. Berkhout B, Floris R, Recio I, Visser S. The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals 2004; 17: 291-4.
19. Tuccari G, Villari D, Giuffrè G et al. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease. Histol. Histopathol. 2002; 17: 1077-83.
20. Hara K, Ikeda M, Saito S et al. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res. 2002; 24: 228-35.
21. 2 microglobulin levels in monitoring chronic hepatitis B. Tohoku J. Exp. Med. 2004; 203: 53-7.
22. Akdogan M, Senturk H, Mert A, Tabak F, Ozbay G. Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels. J. Gastroenterol. 2003; 38: 465-70.